CATIP
gene geneOn this page
Also known as MGC50811
Summary
CATIP (ciliogenesis associated TTC17 interacting protein, HGNC:25062) is a protein-coding gene on chromosome 2q35, encoding Ciliogenesis-associated TTC17-interacting protein (Q7Z7H3). Plays a role in primary ciliogenesis by modulating actin polymerization.
Involved in actin filament polymerization and cilium organization. Located in several cellular components, including actin cytoskeleton; nucleus; and plasma membrane. Implicated in spermatogenic failure 54.
Source: NCBI Gene 375307 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 56 total — 1 likely-pathogenic
- Phenotypes (HPO): 17
- MANE Select transcript:
NM_198559
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25062 |
| Approved symbol | CATIP |
| Name | ciliogenesis associated TTC17 interacting protein |
| Location | 2q35 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC50811 |
| Ensembl gene | ENSG00000158428 |
| Ensembl biotype | protein_coding |
| OMIM | 619387 |
| Entrez | 375307 |
Gene structure
Transcript identifiers
Ensembl transcripts: 11 — 6 protein_coding, 3 retained_intron, 2 protein_coding_CDS_not_defined
ENST00000289388, ENST00000480532, ENST00000481940, ENST00000494447, ENST00000495773, ENST00000715906, ENST00000715907, ENST00000851693, ENST00000851694, ENST00000851695, ENST00000851696
RefSeq mRNA: 2 — MANE Select: NM_198559
NM_001320865, NM_198559
CCDS: CCDS2414
Canonical transcript exons
ENST00000289388 — 10 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001038842 | 218357534 | 218357734 |
| ENSE00001074994 | 218358037 | 218358092 |
| ENSE00001074995 | 218364628 | 218364752 |
| ENSE00001075001 | 218362735 | 218362902 |
| ENSE00001339360 | 218357095 | 218357187 |
| ENSE00001339369 | 218356857 | 218356909 |
| ENSE00001869443 | 218367722 | 218368094 |
| ENSE00003507596 | 218360573 | 218360659 |
| ENSE00003562236 | 218367430 | 218367518 |
| ENSE00003637600 | 218367024 | 218367100 |
Expression profiles
Bgee: expression breadth ubiquitous, 129 present calls, max score 95.62.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1955 / max 9.7597, expressed in 108 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 25314 | 0.1482 | 84 |
| 25313 | 0.0472 | 23 |
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 95.62 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 87.63 | gold quality |
| fallopian tube | UBERON:0003889 | 80.48 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 76.80 | gold quality |
| thyroid gland | UBERON:0002046 | 75.82 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 75.39 | gold quality |
| blood | UBERON:0000178 | 74.90 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 74.73 | gold quality |
| monocyte | CL:0000576 | 74.35 | gold quality |
| right lung | UBERON:0002167 | 74.29 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 73.78 | gold quality |
| leukocyte | CL:0000738 | 73.74 | gold quality |
| left testis | UBERON:0004533 | 73.03 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 72.89 | gold quality |
| granulocyte | CL:0000094 | 72.83 | gold quality |
| testis | UBERON:0000473 | 72.67 | gold quality |
| right testis | UBERON:0004534 | 72.33 | gold quality |
| kidney | UBERON:0002113 | 70.82 | gold quality |
| metanephros cortex | UBERON:0010533 | 70.57 | gold quality |
| left uterine tube | UBERON:0001303 | 70.07 | gold quality |
| adenohypophysis | UBERON:0002196 | 69.95 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 68.38 | gold quality |
| pituitary gland | UBERON:0000007 | 68.37 | gold quality |
| cortex of kidney | UBERON:0001225 | 66.76 | gold quality |
| lung | UBERON:0002048 | 65.91 | gold quality |
| placenta | UBERON:0001987 | 65.39 | gold quality |
| prostate gland | UBERON:0002367 | 64.27 | gold quality |
| body of pancreas | UBERON:0001150 | 63.92 | gold quality |
| bone marrow | UBERON:0002371 | 63.64 | gold quality |
| bone marrow cell | CL:0002092 | 63.51 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 7.32 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
2 targeting CATIP, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-296-5P | 97.61 | 64.02 | 851 |
| HSA-MIR-3189-5P | 97.55 | 66.71 | 655 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | catip | ENSDARG00000063009 |
| mus_musculus | Catip | ENSMUSG00000073650 |
| rattus_norvegicus | Catip | ENSRNOG00000037835 |
Paralogs (1): BAMBI (ENSG00000095739)
Protein
Protein identifiers
Ciliogenesis-associated TTC17-interacting protein — Q7Z7H3 (reviewed: Q7Z7H3)
All UniProt accessions (1): Q7Z7H3
UniProt curated annotations — full annotation on UniProt →
Function. Plays a role in primary ciliogenesis by modulating actin polymerization.
Subunit / interactions. Interacts with TTC17.
Subcellular location. Nucleus. Cytoplasm. Cell membrane. Cytoskeleton.
Tissue specificity. Strongly expressed in round and elongating spermatids, weakly in pachytene spermatocytes. Expressed in Leydig cells (at protein level). Expressed in testis, placenta, prostate and lung, and moderately in ovary and brain.
Disease relevance. Spermatogenic failure 54 (SPGF54) [MIM:619379] An autosomal recessive male infertility disorder characterized by oligoteratoasthenozoospermia. Semen analysis shows markedly reduced sperm counts and severely reduced or absent sperm motility. The disease is caused by variants affecting the gene represented in this entry.
Similarity. Belongs to the CATIP family.
RefSeq proteins (2): NP_001307794, NP_940961* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR047501 | DD_CATIP | Domain |
| IPR048777 | CATIP_N | Domain |
Pfam: PF21772
UniProt features (6 total): region of interest 2, compositionally biased region 2, chain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q7Z7H3-F1 | 86.37 | 0.64 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 64 (showing top):
GOBP_CILIUM_ORGANIZATION, GOBP_ACTIN_FILAMENT_ORGANIZATION, GOBP_CELL_PROJECTION_ORGANIZATION, KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3, SMAD4_Q6, GOBP_ACTIN_POLYMERIZATION_OR_DEPOLYMERIZATION, GOBP_PROTEIN_POLYMERIZATION, GOBP_SUPRAMOLECULAR_FIBER_ORGANIZATION, CCTNTMAGA_UNKNOWN, FOXJ2_TARGET_GENES, ZFP91_TARGET_GENES, HP_ABNORMALITY_OF_REPRODUCTIVE_SYSTEM_PHYSIOLOGY, HP_DECREASED_FERTILITY, HP_INFERTILITY, HP_OLIGOZOOSPERMIA
GO Biological Process (3): actin filament polymerization (GO:0030041), cilium organization (GO:0044782), cell projection organization (GO:0030030)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (6): nucleus (GO:0005634), cytoplasm (GO:0005737), plasma membrane (GO:0005886), actin cytoskeleton (GO:0015629), cytoskeleton (GO:0005856), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| actin polymerization or depolymerization | 1 |
| protein polymerization | 1 |
| organelle organization | 1 |
| plasma membrane bounded cell projection organization | 1 |
| cellular component organization | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cytoskeleton | 1 |
| intracellular membraneless organelle | 1 |
Protein interactions and networks
STRING
586 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CATIP | TEX55 | Q96M34 | 582 |
| CATIP | TPGS1 | Q6ZTW0 | 572 |
| CATIP | VWC2L | B2RUY7 | 563 |
| CATIP | AK8 | Q96MA6 | 526 |
| CATIP | FBXL13 | Q8NEE6 | 520 |
| CATIP | PCYT1B | Q9Y5K3 | 507 |
| CATIP | ROPN1L | Q96C74 | 505 |
| CATIP | ROPN1 | Q9HAT0 | 503 |
| CATIP | ROPN1B | Q9BZX4 | 502 |
| CATIP | EFCAB10 | A6NFE3 | 491 |
| CATIP | CABYR | O75952 | 485 |
| CATIP | OR2K2 | Q8NGT1 | 447 |
| CATIP | ODAD2 | Q5T2S8 | 414 |
| CATIP | ODAD4 | Q96NG3 | 399 |
| CATIP | K7N7A8 | K7N7A8 | 384 |
IntAct
57 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CATIP | KRT31 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRT31 | CATIP | psi-mi:“MI:0915”(physical association) | 0.720 |
| CATIP | psi-mi:“MI:0915”(physical association) | 0.560 | |
| CATIP | KRTAP10-7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-9 | CATIP | psi-mi:“MI:0915”(physical association) | 0.560 |
| CATIP | MTUS2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CATIP | KRT40 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CATIP | CTNNBL1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| BRD9 | CATIP | psi-mi:“MI:0915”(physical association) | 0.560 |
| CEP72 | CATIP | psi-mi:“MI:0915”(physical association) | 0.560 |
| CATIP | psi-mi:“MI:0915”(physical association) | 0.560 | |
| CATIP | KRTAP10-9 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT40 | CATIP | psi-mi:“MI:0915”(physical association) | 0.560 |
| CTNNBL1 | CATIP | psi-mi:“MI:0915”(physical association) | 0.560 |
| CATIP | CEP72 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MTUS2 | CATIP | psi-mi:“MI:0915”(physical association) | 0.560 |
| CATIP | BRD9 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (19): CATIP (Two-hybrid), CATIP (Two-hybrid), CATIP (Two-hybrid), CATIP (Two-hybrid), CATIP (Two-hybrid), CATIP (Two-hybrid), CATIP (Two-hybrid), KRTAP10-7 (Two-hybrid), KRTAP10-9 (Two-hybrid), KRTAP10-3 (Two-hybrid), CATIP (Two-hybrid), CATIP (Two-hybrid), CATIP (Two-hybrid), CATIP (Two-hybrid), HESX1 (Two-hybrid)
ESM2 similar proteins: A0JNQ6, A2RT67, A2RUS2, A6NC42, A6NGQ2, A9X185, O75031, O75817, O94955, O95267, P50747, Q06VW1, Q0II25, Q0ZFW8, Q1RMS8, Q1RMZ1, Q29108, Q2TBA3, Q3T0J1, Q3TYS2, Q4VX76, Q568D5, Q568M3, Q587J7, Q5JSQ8, Q5T9G4, Q5ZLS2, Q62522, Q69ZK0, Q6AYA6, Q6P5G6, Q7Z7H3, Q80X86, Q86WV5, Q8BXK4, Q8C0Q9, Q8CHQ0, Q8TCU6, Q8WUE5, Q91Z62
Diamond homologs: A6NNX1, B9EKE5, M0RAU5, Q0IHI3, Q32PB2, Q3KNY5, Q7Z7H3, Q08CH6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
56 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 1 |
| Uncertain significance | 50 |
| Likely benign | 4 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 1172755 | NM_198559.2(CATIP):c.103T>A (p.Phe35Ile) | Likely pathogenic |
SpliceAI
1858 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:218360571:A:AG | acceptor_gain | 1.0000 |
| 2:218360572:G:GG | acceptor_gain | 1.0000 |
| 2:218364615:T:TA | acceptor_gain | 1.0000 |
| 2:218364626:A:AG | acceptor_gain | 1.0000 |
| 2:218364627:G:GG | acceptor_gain | 1.0000 |
| 2:218364627:GC:G | acceptor_gain | 1.0000 |
| 2:218366570:G:T | donor_gain | 1.0000 |
| 2:218367099:GG:G | donor_gain | 1.0000 |
| 2:218367100:GG:G | donor_gain | 1.0000 |
| 2:218367716:T:TA | acceptor_gain | 1.0000 |
| 2:218367720:A:AG | acceptor_gain | 1.0000 |
| 2:218367721:G:GG | acceptor_gain | 1.0000 |
| 2:218357188:G:GG | donor_gain | 0.9900 |
| 2:218362698:T:TA | acceptor_gain | 0.9900 |
| 2:218362899:C:G | donor_gain | 0.9900 |
| 2:218362903:G:GG | donor_gain | 0.9900 |
| 2:218364616:G:A | acceptor_gain | 0.9900 |
| 2:218364619:T:A | acceptor_gain | 0.9900 |
| 2:218364622:T:A | acceptor_gain | 0.9900 |
| 2:218364627:GCA:G | acceptor_gain | 0.9900 |
| 2:218364627:GCAA:G | acceptor_gain | 0.9900 |
| 2:218364627:GCAAA:G | acceptor_gain | 0.9900 |
| 2:218364750:TGGG:T | donor_loss | 0.9900 |
| 2:218364751:GG:G | donor_gain | 0.9900 |
| 2:218364752:GG:G | donor_gain | 0.9900 |
| 2:218364753:G:GA | donor_loss | 0.9900 |
| 2:218364753:G:GG | donor_gain | 0.9900 |
| 2:218364754:T:A | donor_loss | 0.9900 |
| 2:218364755:GA:G | donor_loss | 0.9900 |
| 2:218365618:T:TA | acceptor_gain | 0.9900 |
AlphaMissense
2533 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:218362818:G:C | R182S | 0.982 |
| 2:218362818:G:T | R182S | 0.982 |
| 2:218362817:G:C | R182T | 0.978 |
| 2:218364752:G:A | G252E | 0.975 |
| 2:218367791:T:C | F331L | 0.972 |
| 2:218367793:C:A | F331L | 0.972 |
| 2:218367793:C:G | F331L | 0.972 |
| 2:218367840:C:A | A347D | 0.972 |
| 2:218362817:G:T | R182M | 0.970 |
| 2:218362859:T:C | F196S | 0.966 |
| 2:218364752:G:T | G252V | 0.966 |
| 2:218367836:T:C | F346L | 0.964 |
| 2:218367838:C:A | F346L | 0.964 |
| 2:218367838:C:G | F346L | 0.964 |
| 2:218367504:T:C | F303L | 0.962 |
| 2:218367506:C:A | F303L | 0.962 |
| 2:218367506:C:G | F303L | 0.962 |
| 2:218364751:G:T | G252W | 0.961 |
| 2:218367792:T:C | F331S | 0.959 |
| 2:218367514:G:C | R306P | 0.958 |
| 2:218362858:T:C | F196L | 0.957 |
| 2:218362860:C:A | F196L | 0.957 |
| 2:218362860:C:G | F196L | 0.957 |
| 2:218367025:C:G | H253D | 0.957 |
| 2:218367032:C:A | A255D | 0.956 |
| 2:218367474:T:A | W293R | 0.956 |
| 2:218367474:T:C | W293R | 0.956 |
| 2:218357612:T:C | L66P | 0.954 |
| 2:218367848:T:C | F350L | 0.953 |
| 2:218367850:C:A | F350L | 0.953 |
dbSNP variants (sampled 300 via entrez): RS1000097055 (2:218366957 A>G), RS1000149248 (2:218367349 T>A,C), RS1000726209 (2:218358816 C>T), RS1000864296 (2:218365105 A>C), RS1001614594 (2:218362556 A>C,G,T), RS1001794094 (2:218368305 C>T), RS1001855154 (2:218363757 T>C), RS1001869450 (2:218366429 G>A), RS1002127160 (2:218360351 C>G,T), RS1002344706 (2:218357712 G>A,C), RS1002351421 (2:218363978 G>A,T), RS1002509571 (2:218355874 T>G), RS1002627450 (2:218359061 G>A,T), RS1002678374 (2:218359363 A>T), RS1002712220 (2:218361796 C>T)
Disease associations
OMIM: gene MIM:619387 | disease phenotypes: MIM:619379
GenCC curated gene-disease
Mondo (2): spermatogenic failure 54 (MONDO:0023664), breast ductal adenocarcinoma (MONDO:0005590)
Orphanet (0):
HPO phenotypes
17 total (17 of 17 shown, HPO-id order):
| HPO | Term |
|---|---|
| HP:0000007 | Autosomal recessive inheritance |
| HP:0000027 | Azoospermia |
| HP:0000118 | Phenotypic abnormality |
| HP:0000798 | Oligozoospermia |
| HP:0000837 | Increased circulating gonadotropin level |
| HP:0003251 | Male infertility |
| HP:0008669 | Abnormal spermatogenesis |
| HP:0008734 | Decreased testicular size |
| HP:0011462 | Young adult onset |
| HP:0011961 | Non-obstructive azoospermia |
| HP:0011962 | Obstructive azoospermia |
| HP:0012207 | Reduced sperm motility |
| HP:0030974 | Cryptozoospermia |
| HP:0032559 | Short sperm flagella |
| HP:0032560 | Coiled sperm flagella |
| HP:0032562 | Tapered sperm head |
| HP:0033524 | Abnormal sperm axoneme morphology |
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST90020028_758 | Hip circumference adjusted for BMI | 1.000000e-08 |
| GCST90020028_760 | Hip circumference adjusted for BMI | 8.000000e-12 |
| GCST90020028_761 | Hip circumference adjusted for BMI | 9.000000e-09 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0008039 | BMI-adjusted hip circumference |
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| D018270 | Carcinoma, Ductal, Breast | C04.557.470.200.025.232.500; C04.557.470.615.132.500; C04.588.180.390; C17.800.090.500.390 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
16 total (human), top 16 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | increases expression | 1 |
| dimethylselenide | increases expression, increases oxidation | 1 |
| jinfukang | affects cotreatment, increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | increases expression | 1 |
| Cisplatin | increases expression, affects cotreatment | 1 |
| Ozone | increases oxidation, increases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Smoke | increases abundance, increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Hydroxyl Radical | increases expression, increases oxidation | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
11 trials via MONDO — disease-level, not drug-specific.
| Trial | Phase | Status | Title |
|---|---|---|---|
| NCT03414970 | PHASE3 | ACTIVE_NOT_RECRUITING | Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer |
| NCT00461344 | PHASE2 | TERMINATED | Docetaxel + Doxorubicin as Neoadjuvant Chemotherapy in Patients With Breast Cancer |
| NCT07499999 | PHASE2 | NOT_YET_RECRUITING | Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk for Breast Cancer |
| NCT00637364 | PHASE1/PHASE2 | SUSPENDED | High Intensity Focused Ultrasound Tumor Treatment for Pancreatic Cancer Pain |
| NCT02779855 | PHASE1/PHASE2 | COMPLETED | Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer |
| NCT01753908 | EARLY_PHASE1 | COMPLETED | Broccoli Sprout Extract in Treating Patients With Breast Cancer |
| NCT01796041 | EARLY_PHASE1 | COMPLETED | Intraoperative Imaging of Breast Cancer With Indocyanine Green |
| NCT01208974 | Not specified | ACTIVE_NOT_RECRUITING | Nipple-Areola Complex (NAC) Irradiation After Nipple-Sparing Mastectomy and Reconstruction |
| NCT01875198 | Not specified | TERMINATED | Oncologic Impact of Splenectomy-omitting Radical Pancreatectomy in Well-selected Left-sided Pancreatic Cancer |
| NCT03543397 | Not specified | UNKNOWN | MRI in Ductal Carcinoma in Situ (DCIS) |
| NCT03834532 | Not specified | COMPLETED | Living Well After Breast Surgery |
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): spermatogenic failure 54